Anqi Zhang

Anhui Province Key Laboratory Of Major Autoimmune Diseases
Hefei, 230032, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

ASIC1a promotes alveolar epithelial apoptosis and acute lung injury through repression of the LncRNA00178/miR-466b-3p/Gucy1b1 ceRNA network.

ASIC1a promotes alveolar epithelial apoptosis and acute lung injury through repression of the LncRNA00178/miR-466b-3p/Gucy1b1 ceRNA network.

Journal: International immunopharmacology
Published: November 25, 2025

Acid-sensing ion channel 1a promotes LPS-induced acute lung injury through the circRNA 18-658/miR-127-5p/TRIM72 axis.

Acid-sensing ion channel 1a promotes LPS-induced acute lung injury through the circRNA 18-658/miR-127-5p/TRIM72 axis.

Journal: Molecular immunology
Published: December 17, 2024

ASIC1a regulates ferroptosis in hepatic stellate cells via the Hippo/Yap-1 pathway in liver fibrosis.

ASIC1a regulates ferroptosis in hepatic stellate cells via the Hippo/Yap-1 pathway in liver fibrosis.

Journal: International immunopharmacology
Published: June 16, 2024

Bioinspired Engineering of Fillable Gradient Structure into Flexible Capacitive Pressure Sensor Toward Ultra-High Sensitivity and Wide Working Range.

Bioinspired Engineering of Fillable Gradient Structure into Flexible Capacitive Pressure Sensor Toward Ultra-High Sensitivity and Wide Working Range.

Journal: Macromolecular rapid communications
Published: July 12, 2023

Kaempferol attenuates carbon tetrachloride (CCl4)-induced hepatic fibrosis by promoting ASIC1a degradation and suppression of the ASIC1a-mediated ERS.

Kaempferol attenuates carbon tetrachloride (CCl4)-induced hepatic fibrosis by promoting ASIC1a degradation and suppression of the ASIC1a-mediated ERS.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 20, 2023

Research progress of metformin in the treatment of liver fibrosis.

Research progress of metformin in the treatment of liver fibrosis.

Journal: International immunopharmacology
Published: October 29, 2022

N-phenethyl-5-phenylpicolinamide alleviates inflammation in acute lung injury by inhibiting HIF-1α/glycolysis/ASIC1a pathway.

N-phenethyl-5-phenylpicolinamide alleviates inflammation in acute lung injury by inhibiting HIF-1α/glycolysis/ASIC1a pathway.

Journal: Life sciences
Published: August 11, 2022

ASIC1a induces mitochondrial apoptotic responses in acute lung injury.

ASIC1a induces mitochondrial apoptotic responses in acute lung injury.

Journal: European journal of pharmacology
Published: July 05, 2022
Showing 1-8 of 8

Last Updated: 09/26/2026